Del-zota produced statistically significant increases in exon skipping and dystrophin levels in EXPLORE44, a Phase 1/2 study in patients with DMD44 (oral presentation) Aravindhan Veerapandiyan, MD, ...
- Presentation on ACHIEVE Trial in DM1 and Company Symposium to Feature Data on the Use of Splicing Correction as a Prognostic Biomarker of Functional Outcomes in DM1 - Poster sessions are from 6:00 p ...
Last week, NPR’s "All Things Considered" covered an unusual topic: Scientific conference posters. For the first time in decades, scientists are rethinking the traditional design of the posters they ...
Scientific paper accepted for presentation at American Roentgen Ray Society Annual Meeting, Chicago, IL, May 1-6, 2011. McArthur TA, Lockhart ME, Planz V, Fineberg NS, and Berland LL. CT of the Common ...
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing ...
TORONTO--(BUSINESS WIRE)--Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a public biotech company developing new small molecule therapeutic approaches to improve the ...
UROP celebrates undergraduate engagement in academic and professional conferences, providing $48,650 to support 134 student presentations around the globe in fiscal year 2025. Funding is provided, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results